Loading clinical trials...
Loading clinical trials...
Effect of Oral Administration of Methylene Blue MMX Tablets on Double-stranded DNA Damage Assessed by GammaH2AX Analysis of Colon Biopsy Samples
Conditions
Interventions
standard white light colonoscopy-equivalent to placebo
Methylene Blue MMX tablets
Locations
1
Italy
IRCCS Instituto Clinico Humanitas
Rozzano, Italy
Start Date
February 1, 2013
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
November 5, 2018
NCT04704661
NCT06696768
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Cosmo Technologies Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions